Literature DB >> 33405427

Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots.

Prajna Anirvan1, Sonali Narain2,3, Negin Hajizadeh3,4,5, Fuad Z Aloor3, Shivaram P Singh1, Sanjaya K Satapathy6.   

Abstract

Liver dysfunction manifesting as elevated aminotransferase levels has been a common feature of coronavirus disease-2019 (COVID-19) infection. The mechanism of liver injury in COVID-19 infection is unclear. However, it has been hypothesized to be a result of direct cytopathic effects of the virus, immune dysfunction and cytokine storm-related multiorgan damage, hypoxia-reperfusion injury and idiosyncratic drug-induced liver injury due to medications used in the management of COVID-19. The favored hypothesis regarding the pathophysiology of liver injury in the setting of COVID-19 is cytokine storm, an aberrant and unabated inflammatory response leading to hyperproduction of cytokines. In the current review, we have summarized the potential pathophysiologic mechanisms of cytokine-induced liver injury based on the reported literature.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33405427     DOI: 10.1097/MEG.0000000000002034

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

Review 1.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 2.  The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Authors:  Ren-Jun Hsu; Wei-Chieh Yu; Guan-Ru Peng; Chih-Hung Ye; SuiYun Hu; Patrick Chun Theng Chong; Kah Yi Yap; Jamie Yu Chieh Lee; Wei-Chen Lin; Shu-Han Yu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

3.  Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.

Authors:  Sanjaya K Satapathy; Nitzan C Roth; Charlotte Kvasnovsky; Jamie S Hirsch; Arvind J Trindade; Ernesto Molmenti; Matthew Barish; David Hirschwerk; Ben L Da; David Bernstein
Journal:  Hepatol Int       Date:  2021-04-07       Impact factor: 6.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.